172 related articles for article (PubMed ID: 27566395)
1. Label-free and high-sensitive detection of Kirsten rat sarcoma viral oncogene homolog and epidermal growth factor receptor mutation using Kelvin probe force microscopy.
Jang K; Choi J; Park C; Na S
Biosens Bioelectron; 2017 Jan; 87():222-228. PubMed ID: 27566395
[TBL] [Abstract][Full Text] [Related]
2. Highly sensitive and selective detection of single-nucleotide polymorphisms using gold nanoparticle MutS enzymes and a micro cantilever resonator.
Park C; Kang J; Baek I; You J; Jang K; Na S
Talanta; 2019 Dec; 205():120154. PubMed ID: 31450442
[TBL] [Abstract][Full Text] [Related]
3. Visual DNA microarray for detection of epidermal growth factor receptor (EGFR) gene mutations.
Xue L; Fei JJ; Song Y; Xu RH; Bai YJ
Scand J Clin Lab Invest; 2014 Nov; 74(8):693-9. PubMed ID: 25223598
[TBL] [Abstract][Full Text] [Related]
4. EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations.
Chiosea S; Shuai Y; Cieply K; Nikiforova MN; Dacic S
Hum Pathol; 2010 Aug; 41(8):1053-60. PubMed ID: 20381121
[TBL] [Abstract][Full Text] [Related]
5. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
[TBL] [Abstract][Full Text] [Related]
6. EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect.
Sahnane N; Frattini M; Bernasconi B; Zappa F; Schiavone G; Wannesson L; Antonelli P; Balzarini P; Sessa F; Mazzucchelli L; Tibiletti MG; Martin V
Clin Lung Cancer; 2016 Jan; 17(1):56-61. PubMed ID: 26381283
[TBL] [Abstract][Full Text] [Related]
7. Impact of epidermal growth factor receptor and KRAS mutations on clinical outcome in resected non-small cell lung cancer patients.
Ragusa M; Vannucci J; Ludovini V; Bianconi F; Treggiari S; Tofanetti FR; Flacco A; Colella R; Sidoni A; Crinò L; Puma F
Am J Clin Oncol; 2014 Aug; 37(4):343-9. PubMed ID: 23357969
[TBL] [Abstract][Full Text] [Related]
8. Kras gene codon 12 mutation detection enabled by gold nanoparticles conducted in a nanobioarray chip.
Sedighi A; Li PC
Anal Biochem; 2014 Mar; 448():58-64. PubMed ID: 24291640
[TBL] [Abstract][Full Text] [Related]
9. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
[TBL] [Abstract][Full Text] [Related]
10. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
Li W; Zhang Z; Guo L; Qiu T; Ling Y; Cao J; Guo H; Zhao H; Li L; Ying J
Oncotarget; 2016 Feb; 7(7):8332-40. PubMed ID: 26789109
[TBL] [Abstract][Full Text] [Related]
11. Zeptomole Biosensing of DNA with Flexible Selectivity Based on Acoustic Levitation of a Single Microsphere Binding Gold Nanoparticles by Hybridization.
Miyagawa A; Harada M; Okada T
ACS Sens; 2018 Sep; 3(9):1870-1875. PubMed ID: 30152225
[TBL] [Abstract][Full Text] [Related]
12. An ultrasensitive and simple fluorescence biosensor for detection of the Kras wild type by using the three-way DNA junction-driven catalyzed hairpin assembly strategy.
Li Q; Zhou D; Pan J; Liu Z; Chen J
Analyst; 2019 May; 144(9):3088-3093. PubMed ID: 30919845
[TBL] [Abstract][Full Text] [Related]
13. Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer.
Lozano MD; Labiano T; Echeveste J; Gurpide A; Martín-Algarra S; Zhang G; Sharma A; Palma JF
Cancer Cytopathol; 2015 Apr; 123(4):230-6. PubMed ID: 25529460
[TBL] [Abstract][Full Text] [Related]
14. Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: a meta-analysis.
Song QB; Wang Q; Hu WG
World J Gastroenterol; 2015 Apr; 21(14):4365-72. PubMed ID: 25892888
[TBL] [Abstract][Full Text] [Related]
15. Extremely sensitive and wide-range silver ion detection via assessing the integrated surface potential of a DNA-capped gold nanoparticle.
Lee D; Lee H; Lee G; Kim I; Lee SW; Kim W; Lee SW; Lee JH; Park J; Yoon DS
Nanotechnology; 2019 Feb; 30(8):085501. PubMed ID: 30524017
[TBL] [Abstract][Full Text] [Related]
16. Gold-nanoparticle-based colorimetric discrimination of cancer-related point mutations with picomolar sensitivity.
Valentini P; Fiammengo R; Sabella S; Gariboldi M; Maiorano G; Cingolani R; Pompa PP
ACS Nano; 2013 Jun; 7(6):5530-8. PubMed ID: 23697628
[TBL] [Abstract][Full Text] [Related]
17. Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1).
Beau-Faller M; Degeorges A; Rolland E; Mounawar M; Antoine M; Poulot V; Mauguen A; Barbu V; Coulet F; Prétet JL; Bièche I; Blons H; Boyer JC; Buisine MP; de Fraipont F; Lizard S; Olschwang S; Saulnier P; Prunier-Mirebeau D; Richard N; Danel C; Brambilla E; Chouaid C; Zalcman G; Hainaut P; Michiels S; Cadranel J
J Thorac Oncol; 2011 Jun; 6(6):1006-15. PubMed ID: 21532509
[TBL] [Abstract][Full Text] [Related]
18. EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung.
Jia XL; Chen G
Lung Cancer; 2011 Dec; 74(3):396-400. PubMed ID: 21592614
[TBL] [Abstract][Full Text] [Related]
19. A smart DNA-gold nanoparticle probe for detecting single-base changes on the platform of a quartz crystal microbalance.
Li H; Xiao S; Yao D; Lam MH; Liang H
Chem Commun (Camb); 2015 Mar; 51(22):4670-3. PubMed ID: 25690314
[TBL] [Abstract][Full Text] [Related]
20. A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases.
Monaco SE; Nikiforova MN; Cieply K; Teot LA; Khalbuss WE; Dacic S
Hum Pathol; 2010 Jan; 41(1):94-102. PubMed ID: 19740513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
